Paula Álvarez-Chaver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paula Álvarez-Chaver has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Ana M. Rodríguez-Piñeiro
2 shared publicationsMaría Páez De La Cadena
Paula Álvarez-Chaver, Unidad de Proteómica, Servicio de Determinación Estructural, Proteómica y Genómica, Centro de Apoyo Científico y Tecnológico a la Investigación, Universidad de Vigo, Campus As Lagoas-Marcosende, 36310 Vigo (Pontevedra), Spain
2 shared publicationsMaría Páez de la Cadena
2 shared publications- Vicenta Soledad Martínez-Zorzano
Department of Biochemistry, Genetics and Immunology, Centro Singular de Investigación de Galicia (CINBIO), University of Vigo, Campus As Lagoas-Marcosende s/n, 36310 Vigo, Spain
2 shared publications A. García-Lorenzo
Departamento de Bioquímica, Genética e Inmunología, Universidad de Vigo, Vigo, Spain
1 shared publication- Ana Concheiro-Guisán
Department of Paediatrics, Alvaro Cunqueiro University Hospital, Vigo, Spain
1 shared publication
Latest Publications
- 5 September 2023
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 15 (37) , 4905-4917
Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery
The growth and development of the human brain is a long and complex process that requires a precise sequence of genetic and molecular events.
- 5 September 2023
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 15 (37) , 4905-4917
Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery
The growth and development of the human brain is a long and complex process that requires a precise sequence of genetic and molecular events.
- 1 June 2014
- Published by Elsevier in Journal of Proteomics
- Vol. 105, 151-163
Proteomic characterization of the hemolymph of Octopus vulgaris infected by the protozoan parasite Aggregata octopiana
- 1 June 2014
- Published by Elsevier in Journal of Proteomics
- Vol. 105, 151-163
Proteomic characterization of the hemolymph of Octopus vulgaris infected by the protozoan parasite Aggregata octopiana
- Open Access
- 1 January 2014
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (14) , 3804-24
Proteomics for discovery of candidate colorectal cancer biomarkers
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in Europe and other Western countries, mainly due to the lack of well-validated clinically useful biomarkers with enough sensitivity and specificity to detect this disease at early stages. Although it is well known that the pathogenesis of CRC is a progressive accumulation of mutations in multiple genes, much less is known at the proteome level. Therefore, in the last years many proteomic studies have been conducted to find new candidate protein biomarkers for diagnosis, prognosis and as therapeutic targets for this malignancy, as well as to elucidate the molecular mechanisms of colorectal carcinogenesis. An important advantage of the proteomic approaches is the capacity to look for multiple differentially expressed proteins in a single study. This review provides an overview of the recent reports describing the different proteomic tools used for the discovery of new protein markers for CRC such as two-dimensional electrophoresis methods, quantitative mass spectrometry-based techniques or protein microarrays. Additionally, we will also focus on the diverse biological samples used for CRC biomarker discovery such as tissue, serum and faeces, besides cell lines and murine models, discussing their advantages and disadvantages, and summarize the most frequently identified candidate CRC markers.
- 1 January 2014
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (14) , 3804-24
Open AccessProteomics for discovery of candidate colorectal cancer biomarkers
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in Europe and other Western countries, mainly due to the lack of well-validated clinically useful biomarkers with enough sensitivity and specificity to detect this disease at early stages. Although it is well known that the pathogenesis of CRC is a progressive accumulation of mutations in multiple genes, much less is known at the proteome level. Therefore, in the last years many proteomic studies have been conducted to find new candidate protein biomarkers for diagnosis, prognosis and as therapeutic targets for this malignancy, as well as to elucidate the molecular mechanisms of colorectal carcinogenesis. An important advantage of the proteomic approaches is the capacity to look for multiple differentially expressed proteins in a single study. This review provides an overview of the recent reports describing the different proteomic tools used for the discovery of new protein markers for CRC such as two-dimensional electrophoresis methods, quantitative mass spectrometry-based techniques or protein microarrays. Additionally, we will also focus on the diverse biological samples used for CRC biomarker discovery such as tissue, serum and faeces, besides cell lines and murine models, discussing their advantages and disadvantages, and summarize the most frequently identified candidate CRC markers.
- 31 May 2012
- Published by Proteomass Scientific Society in Journal of Integrated OMICS
- Vol. 2 (1)
Multivariate methods aid in pinpointing promising tumor marker candidates from colorectal biopsies
The application of proteomic techniques to the search for disease markers is widely reported nowadays. However, the data rendered by these methods is highly complex and requires mining through statistical methods. Since univariate tests are prone to false positives and require post-test correction, multivariate methods seem more suitable for the task. Here we show an example of their utility, applying both principal component analysis (PCA) and linear discriminant analysis (LDA) to the hydrophobic subproteome of the colorectal mucosa. In order to find proteins specifically altered by colorectal cancer, we compared both the tumor and the adjacent healthy mucosa. PCA followed by variable selection, and corroboration by LDA, pointed out the proteins vimentin and prohibitin as promising candidates for the diagnosis of colorectal tumors
- 31 May 2012
- Published by Proteomass Scientific Society in Journal of Integrated OMICS
- Vol. 2 (1)
Multivariate methods aid in pinpointing promising tumor marker candidates from colorectal biopsies
The application of proteomic techniques to the search for disease markers is widely reported nowadays. However, the data rendered by these methods is highly complex and requires mining through statistical methods. Since univariate tests are prone to false positives and require post-test correction, multivariate methods seem more suitable for the task. Here we show an example of their utility, applying both principal component analysis (PCA) and linear discriminant analysis (LDA) to the hydrophobic subproteome of the colorectal mucosa. In order to find proteins specifically altered by colorectal cancer, we compared both the tumor and the adjacent healthy mucosa. PCA followed by variable selection, and corroboration by LDA, pointed out the proteins vimentin and prohibitin as promising candidates for the diagnosis of colorectal tumors
- 31 January 2012
- Published by Taylor & Francis in Cancer Investigation
- Vol. 30 (1) , 72-78
Secreted Clusterin in Colon Tumor Cell Models and Its Potentialas Diagnostic Marker for Colorectal Cancer
We studied the specific changes of the secreted protein clusterin and its cytoplasmic precursor regarding colorectal tumorigenesis, using in vitro differentiation of Caco-2 cells. In tumor-like stage, we observed an overexpression of both precursor and secreted clusterin, corroborated in the cell line SW-480. Noticeably, SW-620 cells (from a tumoral node, thus with metastatic capacity) did not show overexpression of either precursor or secreted clusterin, suggesting a downregulation related to local metastasis. We further investigated clusterin in serum, finding a significant increase in colorectal cancer patients, with 81% sensitivity, 79% specificity, and an area under the ROC curve of 0.85.
- 31 January 2012
- Published by Taylor & Francis in Cancer Investigation
- Vol. 30 (1) , 72-78
Secreted Clusterin in Colon Tumor Cell Models and Its Potentialas Diagnostic Marker for Colorectal Cancer
We studied the specific changes of the secreted protein clusterin and its cytoplasmic precursor regarding colorectal tumorigenesis, using in vitro differentiation of Caco-2 cells. In tumor-like stage, we observed an overexpression of both precursor and secreted clusterin, corroborated in the cell line SW-480. Noticeably, SW-620 cells (from a tumoral node, thus with metastatic capacity) did not show overexpression of either precursor or secreted clusterin, suggesting a downregulation related to local metastasis. We further investigated clusterin in serum, finding a significant increase in colorectal cancer patients, with 81% sensitivity, 79% specificity, and an area under the ROC curve of 0.85.
- 16 May 2011
- Published by Elsevier in Journal of Proteomics
- Vol. 74 (6) , 874-886
Selection of putative colorectal cancer markers by applying PCA on the soluble proteome of tumors: NDK A as a promising candidate
- 16 May 2011
- Published by Elsevier in Journal of Proteomics
- Vol. 74 (6) , 874-886
Selection of putative colorectal cancer markers by applying PCA on the soluble proteome of tumors: NDK A as a promising candidate
- 1 January 2007
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 39 (3) , 529-540
Identification of hydrophobic proteins as biomarker candidates for colorectal cancer
- 1 January 2007
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 39 (3) , 529-540
Identification of hydrophobic proteins as biomarker candidates for colorectal cancer